Loading organizations...
Drug discovery company developing novel kinase inhibitors for health care.
Confluence Life Sciences has raised $4.0M across 1 funding round.
Confluence Life Sciences has raised $4.0M in total across 1 funding round.
Confluence Life Sciences has raised $4.0M in total across 1 funding round.
Confluence Life Sciences's investors include Danny Janiak, BioGenerator, Helix Fund, Missouri Technology Corporation.
Confluence Life Sciences has raised $4.0M across 1 funding round. Most recently, it raised $4.0M Series A in September 2012.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Sep 17, 2012 | $4.0M Series A | Danny Janiak | BioGenerator, Helix Fund, Missouri Technology Corporation |